Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
1,340.40
1,232.54
1,031.27
886.33
710.16
687.62
501.43
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,340.40
1,232.54
1,031.27
886.33
710.16
687.62
501.43
Raw Material Cost
420.41
375.69
326.45
320.93
283.55
209.24
150.45
Purchase of Finished goods
277.69
301.56
200.00
88.55
39.27
96.18
60.76
(Increase) / Decrease In Stocks
-127.70
-157.07
-30.97
28.56
14.86
-2.16
45.72
Employee Cost
202.19
164.64
139.37
116.29
103.84
86.58
81.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
-0.01
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
323.19
272.48
180.51
178.88
131.20
144.61
-353.47
Total Expenditure (Excl Depreciation)
1,095.78
957.30
815.36
733.20
572.72
534.45
-14.77
Operating Profit (PBDIT) excl Other Income
244.62
275.24
215.91
153.13
137.44
153.17
516.20
Other Income
27.21
14.88
29.09
30.65
14.45
3.85
10.06
Operating Profit (PBDIT)
271.83
290.12
245.00
183.78
151.89
157.02
526.26
Interest
11.88
5.56
3.20
4.34
2.47
3.48
5.06
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
259.95
284.56
241.80
179.44
149.42
153.54
521.20
Depreciation
50.02
39.95
31.21
25.17
14.86
26.24
9.71
Profit Before Tax
209.93
244.62
210.59
154.28
134.56
127.30
61.27
Tax
52.59
57.79
56.31
33.97
25.67
27.20
12.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
157.34
186.83
154.29
120.31
108.89
100.10
48.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
157.34
186.83
154.29
120.31
108.89
100.10
48.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.77
-1.36
-2.11
0.66
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
156.57
185.47
152.18
120.97
108.89
100.10
48.45
Equity Capital
45.32
45.32
45.32
40.42
40.93
40.93
40.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
2,236.08
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.45
4.09
3.36
2.99
2.66
2.45
1.18
Diluted Earnings per share
3.45
4.09
3.36
2.99
2.62
2.41
1.15
Operating Profit Margin (Excl OI)
18.25%
22.33%
20.94%
17.28%
19.35%
22.28%
102.95%
Gross Profit Margin
19.39%
23.09%
23.45%
20.25%
21.04%
22.33%
103.94%
PAT Margin
11.74%
15.16%
14.96%
13.57%
15.33%
14.56%
9.66%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 8.75% vs 19.52% in Sep 2024
Consolidate Net Profit
Growth in half year ended Sep 2025 is -15.58% vs 21.88% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is -11.12% vs 27.48% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 113.67% vs 73.75% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of Marksans Pharma With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
1,340.40
0
1,340.40
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,340.40
0
1,340.40
Raw Material Cost
420.41
0
420.41
Purchase of Finished goods
277.69
0
277.69
(Increase) / Decrease In Stocks
-127.70
0
-127.70
Employee Cost
202.19
0
202.19
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
323.19
0.00
323.19
Total Expenditure (Excl Depreciation)
1,095.78
0
1,095.78
Operating Profit (PBDIT) excl Other Income
244.62
0.00
244.62
Other Income
27.21
0
27.21
Operating Profit (PBDIT)
271.83
0
271.83
Interest
11.88
0
11.88
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
259.95
0
259.95
Depreciation
50.02
0
50.02
Profit Before Tax
209.93
0
209.93
Tax
52.59
0
52.59
Provisions and contingencies
0.00
0
0.00
Profit After Tax
157.34
0
157.34
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
157.34
0
157.34
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.77
0
-0.77
Other related items
0.00
0.00
0.00
Consolidated Net Profit
156.57
0
156.57
Equity Capital
45.32
0
45.32
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
3.45
0
3.45
Diluted Earnings per share
3.45
0
3.45
Operating Profit Margin (Excl OI)
18.25%
0%
0.00
18.25%
Gross Profit Margin
19.39%
0%
0.00
19.39%
PAT Margin
11.74%
0%
0.00
11.74%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 1,340.40 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 8.75% vs 19.52% in Sep 2024
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 156.57 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -15.58% vs 21.88% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 244.62 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -11.12% vs 27.48% in Sep 2024
Half Yearly - Interest
Interest 11.88 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 113.67% vs 73.75% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.25%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
